Drug interactions
Dexamethasone-tobramycin + Vemurafenib
Severity: Minor
Dexamethasone-tobramycin and Vemurafenib: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Vemurafenib inhibits P-glycoprotein and could raise exposure to dexamethasone, which is a P-gp substrate. The effect is likely small and the practical significance limited.
What this interaction means in plain words
Dexamethasone-tobramycin and Vemurafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Dexamethasone-tobramycin belongs to Anti Bacterial; Vemurafenib belongs to Oncology.
Why it happens
Inhibition of P-glycoprotein efflux by vemurafenib may modestly increase dexamethasone exposure.
What to do
No routine change is needed; monitor for corticosteroid adverse effects with prolonged systemic dexamethasone.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dexamethasone-tobramycin and Vemurafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone-tobramycin
Other interactions of Vemurafenib
Frequently asked questions
Can I take Dexamethasone-tobramycin with Vemurafenib?
MediHelp rates the interaction as minor. Dexamethasone-tobramycin and Vemurafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vemurafenib inhibits P-glycoprotein and could raise exposure to dexamethasone, which is a P-gp substrate. The effect is likely small and the practical significance limited.
How serious is the interaction between Dexamethasone-tobramycin and Vemurafenib?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed; monitor for corticosteroid adverse effects with prolonged systemic dexamethasone.
What other medicines interact with Dexamethasone-tobramycin?
MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
